20
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Literature Alerts

Pages 393-406 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • 186 Re/188Re labeled polypeptide microspheres as a potential radiation synovectomy agent. JIA, W., EHRHARDT, G. J., ZINN, K., WANG, N., and KETRING, A. R., y Radioanal Nucl Chem, 1996, 206, 107–117.
  • A 1H nuclear magnetic resonance method for investigating the phospholipase D-catalyzed hydrolysis of phosphatidylcholine in liposomes. DOROVSKA, T. V., Wick, R., and WALDE, P., Anal. Biochem., 240 (1), 37–47.
  • A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. WILLIAMS, A. S., CAMILLERI, J. P., GOODFELLOW, R. M., and WILLIAMS, B. D. Br., J. Rheumatol., 1996, 35 (8), 719–724.
  • A study of the interaction of adrenocorticotropin-(1-24)-tetracosapeptide with BLM and liposomes. HIANIK, T., KRIVANEK, R., SARGENT, D. F., SOKOLIKOVA, L., and VINCEOVA, K., Prog. Colloid Polym. Sci., 1996, 100, 301–305.
  • A novel plating process for microencapsulating metal hydrides. LAW, H. H., VYAS, B., ZAHURAK, S. M., and KAMMLOTT, G. W., J. Electrochem. Soc., 1996, 143 (8), 2596–2601.
  • Alginate polycation microcapsules. I. Interaction between alginate and polycation. THU, B., BRUHEIM, P., ESPEVIK, T., SMIDSROD, 0., SOON SHIONG, P., and SKJAK BEtAEK, G., Biomaterials, 1996, 17 (10), 1031–1040.
  • Alginate polycation microcapsules. II. Some functional properties. Tuu, B., BRUHEIM, P., ESPEVIK, T., SMIDSROD, 0., SOON SHIONG, P., and SKJAK BRAEK, G., Biomatenals, 1996, 17 (11), 1069–1079.
  • Alginate/chitosan microporous microspheres for the controlled release of proteins and antigens. HELLER, J., Liu, L. S., NG, S., DUNCAN, R., and RICHARDSON, S., Proc. Int. Syntp. Controlled Release Bioact. Mater., 1996, 23rd, 269–270.
  • Alkali cation transport through liposomes by the antimicrobial fusafungine and its constitu-tive enniatins. LEVY, D., BLUZAT, A., SEIGNEURET, M., and RIGAUD, J. L., Biochem. Pharmacol., 1995, 50 (12), 2105–2107.
  • Amino acid oligomer microspheres as drug delivery systems. I. Synthesis of oligo(amino acids) via NCAs and their microsphere formation. YANG, J. Z., ANTOUN, S., OTTENBRITE, R. M., and MILSTEIN,Bioact. Compat. Polym., 1996, 11(3), 219–235.
  • Amino acid oligomer microspheres as drug delivery systems. II. Oligomerization of NCAs initiated with L-tyrosine methyl ester. YANG, J. Z., WANG, M., OTTENBRITE, R. M., and MILSTEIN,Bioact. Compat. Polym., 1996, 11(3), 236–247.
  • An alternative to radioactive microsphere for measuring regional myocardial blood flow, part 2: Laser-Doppler perfusion monitor. Sin, A., and RUSH, W., y. Cardiothorac. Vasc. Anesth., 1996, 10 (3), 374–377.
  • An alternative to radioactive microspheres for measuring regional myocardial blood flow, part 1: colored microspheres. SIDI, A., and RUSH, W., J. Cardiothorac. Vasc. Anesth., 1996, 10 (3), 368–373.
  • Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th2 cells. AGREWALA, J. N., OWAIS, M., GuF-rA, C. M., and MISHRA, G. C. Cytokines Mol. Thee., 1996, 2 (1), 59–65.
  • Antinociception and side effects of L- and D-dipalmitoylphosphatidyl choline liposome-encapsulated alfentanil after spinal delivery in rats. IsAcKsoN, J., WALLACE, M. S., Ho, R. J., SHEN, D. D., and YAKSH, T. L. Pharmacol. Toxicol., 1995, 77 (5), 333–340.
  • Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit sub-conjunctival fibroblasts in an ex-vivo model. MAIGNEN, F., TILLEUL, P., BILLARDON, C., OPSTAL, W. Y. X. V., PELAPRAT, D., ELENA, P. P., DENIS, P. and ROSTENE, W. I. Ocul. Pharmacol. 1996, 12 (3), 289–298.
  • Antitumor activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. JAMEELA, S. n-ATHA, P. G., SURFtAMONIAM, A., and JAYAKRISHNAN, A., y. Pharm. Pharmacol., 1996, 48 (7), 685–688.
  • Antitumor activity of doxorubicin encapsulated in poly(ethylene glycol)-coated liposomes. HOSODA, J., UNEZAKI, S., MARUYAMA, K., TSUCHIYA, S., and IWATSURU, M., Biol. Phann. Bull., 1995, 18 (9), 1234–1237.
  • Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice. SHARMA, A., STRAUBINGER, R. M., OJIMA, I., and BERNACKI, R. J., J. Pharm. Sci., 1995, 84 (12), 1400–1440.
  • Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. SCHMIDT, W. C., RI1TIG, M., BUCHNER, E., HAUSER, I., SCHMIDT, I., PALOMBO, K. E., EMMRICH, F., and KINNE, R. W., J. Leukocyte Biol., 1996, 60 (2), 230–244.
  • Application of alginate gel as a vehicle for liposomes. I. Factors affecting the loading of drug-containing liposomes and drug release. TAICAGI, I., SHIMIZU, H., and YOTSUYANAGI, T., Chem. Pharm. Bull., 1996, 44 (10), 1941–1947.
  • Application of fusogenic liposomes to treatment of viral diseases. NAKANism, M., and SHIMA, Y., Igaku no Ayumi, 1996, 177 (13), 1006–1009.
  • Application of lipid microspheres for the treatment of cancer. TAKENAGA, M., Adv. Drug Delivery Rev., 1996, 20 (2, 3), 209–219.
  • Archaebacterial lipid models: stable liposomes from 1-alky1-2-phytanyl-sn-glycero-3-phosphocholines. YAMAUCHI, K., Dm, K., and KINOSFHTA, M., Biochim. Biophys. Acta, 1996, 1283 (2), 163–169.
  • Atomic force microscopy of human serum albumin (HSA) on poly(styrene/acrolein) microspheres. KOWALCZYK, D. K., MARSAULT, J. P., and SLOMKOWSKI, S., Colloid Polym. Sci., 1996, 274 (6), 513–519.
  • Availability of liposomes as drug carriers to the brain. KOBAYASHI, K., HAN, M., WATARAI, S., and YASUDA, T., Acta Med. Okayama, 1996, 50 (2), 67–72.
  • Biodegradable indium-111 labeled microspheres for in vivo evaluation of distribution and THANOO, B. C., DOLL, W. J., MEHTA, R. C., DIGENIS, G. A., and DaLucA, P. P., Pharmo. Res., 1995, 12 (12), 2060–2064.
  • Biodistribution and intrahepatic distribution of liposomal vidarabine monophosphate. BARBOSA, C. M., PRISTA, L. V. N., and CRUZ, M. E. M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 651–652.
  • Biological activity and intracellular pharmacokinetics of antisense oligonucleotides: effect of cationic liposomes. TAKAGI, T., KANAMURAU, T., TAKAKURA, Y., and HASHIDA, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 905–906.
  • Biological characterization of L-asparaginase liposomal formulations. GASPAR, M. M., PEREZ, S. R., and CRUZ, M. E. M., Cancer Chemother. Pharmacol., 1996, 38 (4), 373–377.
  • Biomolecular recognition at phospholipid-covered polystyrene microspheres. SICCHIEROLLI, S. M., and CARMONA RIBEIRO, A. M., y. Phys. Chem., 1996, 100 (41), 16771–16775.
  • Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug. YAcm, K., HARASHIMA, H., KIKUCHI, H., SUDO, R., YAMAUCHI, H., EBIHAFIA, K., MATSU°, H., FUNATO, K., and KIWADA, H. Biopharm. Drug Dispos., 1996, 17 (7), 589–605.
  • Blood-pool imaging using technetium-99m-labeled liposomes. Goms, B., PHILLIPS, W. T., and KLIPPER, R., J. Nucl. Med. 1996, 37 (8), 1374–1379.
  • Brain delivery of the cholecystokinin agonist pBC 264 using PLG microspheres. BLANCO, P. M. J., FATTAL, E., DURIEUX, C., ROQUES, B. P., and COUVREUR, P., Proc. mt.Symp. Controlled Release Bioact. Mater., 1996, 23rd, 853–854.
  • Bromoacetylcholine and acetylcholinesterase introduced via liposomes into motor nerve endings block increases in quantal size. BRAILOIU, E., and VAN DER KLOOT, W., Pfluegers Arch., 1996, 432 (3), 413–418.
  • Can the microsphere model by applied to cerebral blood flow measurement using N-isopropyl-p-(123I) iodoamphetamine with SPET regardless of washout from brain tissue? OHKUBO, M., °DAN°, I., TAKAHASHI, N., and SAICAI, K. Nucl. Med. Commun., 1995, 16 (12), 1026–1033.
  • Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. MUROHARA, T., MaacturrA, J., PHILLIPS, L. M., PAuLson, J. C., DEFREES, S., ZALIPSKY, S., Guo, L. S., and LEPER, A. M., Cardiovasc. Res., 1995, 30 (6), 965–974.
  • Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. CHENG, H. Y., RANDALL, C. S., HOLL, W. W., CONSTANTINIDES, P. P., YUE, T. L., and FEUERSTEIN, G. Z., Biochim. Biophys. Acta, 1996, 1284 (1), 20–28.
  • Cationic liposome plasmid DNA complexes. In vitro cell entry, and transgene expression augmented by synthetic signal peptides. CONARY, J. T., ERDOS, G., McGuntE, M., FAULKS, R., GAGNE, L., PRICE, P., CHRISTMAN, B., BRIGHAM, K., EBNER, F., and SCHREIER, H., Eur. y. Pharm. Biopharm., 1996, 42 (4), 277–285.
  • Chain-breaking fused heterocyclic antioxidants: antioxidant activities of 9H-Xanthene-2,7-diols and .alpha.-tocopherol upon liposomal membranes. YAMAMURA, T., and NISHIYAMA, T., Chikyu Kankyo Tekio Kagaku Seisan Gijutsu Kenkyu Hokokusho, 1996, 3, 60–71.
  • Changes in the optical properties of liposome dispersions in relation to the interlamellar distance and solute interaction. VIERA, L. I., SENISTERRA, G. A., and DisaLvo, E. A., Chem. Phys. Lipids, 1996, 81(1), 45–54.
  • Characteristics of drug loadings, drug release and degradation of chitosan microspheres prepared using the dry-in-oil method. YOSHINO, T., MACHIDA, Y., ONISHI, H., and NAGAI, T., STP Pharma. Sci. 1996, 6 (2), 122–128.
  • Characterization of biotinylated liposomes sensitive to temperature and pH: new tools for anti-cancer drug delivery. FERRARETTO, A., SONNINO, S., SORIA, M. R., and MASSERINI, M., Chem. Phys. Lipids, 1996, 82 (2), 133–139.
  • Characterization of ProLease human growth hormone PLGA microspheres produced using different solvents. HERBERGER, J. D., Wu, C., DONG, N., and TRACY, M. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 835–836.
  • Chemical reactions taking advantage of the interface between water and oil. An approach to microcapsules. FUKUDA, K., Pharm. Tech. jpn., 1996, 12(8), 1147–1151.
  • Chitosan microspheres�improved acid stability and change in physicochemical properties by crosslinking. BERTHOLD, A., and KREUTER, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 369–370.
  • Chitosan microspheres for nasal delivery: effect of crosslinking agents on release characteristics. GENTA, I., COSTANTINI, M., and MONTANARI, L., Proc. Int. Symp. Controlled Relase Bioact. Mater., 1996, 23rd, 377–378.
  • Cisplatin incorporated polylactide microspheres blending with water-soluble polymers. YOSHIZAWA, H., UEMURA, Y., NATSUGOE, S., TOKUDA, K., SHIMADA, M., NAKAMURA, K., AIKOU, T., and HATATE, Y. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 381–382.
  • Co-encapsulation of proteins into polylactide microspheres. CONWAY, B. R., and ALPAR, H. 0. Pharm. Sci., 1996, 2 (4), 173–176.
  • Cocaine hydrochloride in poly(L-lactide) microspheres potentiates effects on the locomotion of rats. MASINDE, L. E., BERTELSEN, G. A., SCHLEMMER, R. F. JR., GULATI, A., and HICKEY, A. J., Methods Find. Exp. Clin. Pharmacol., 1996, 17 (9), 597–600.
  • Coloured microsphere assessment of blood flow to knee ligaments in adult rabbits: effects of injury. By, R. C., BUTTERWICK, D. J., DoscHAK, M. R., and TYBERG, J. v., J. Orthop. Res., 1996, 14 (4), 618–625.
  • Comparative study of the kinetics of phospholipid liposome peroxidation, induced by hypochlorite and in the Fe2++ ascorbate system. PANASENKO. 0. M., ARNHOLD, J., ARNHOLD, K., VLADIMIROV, I., and SERGIENKO, V. I., Biofizika, 1996, 41(2), 334–341.
  • Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. THAKUR, C. P., PANDEY, A. K., SINHA, G. P., ROY, S., BEHBEHANI, K., and OLLIARO, P., Trans. R. Soc. Trop. Med. Hyg., 1996, 90 (3), 319–322.
  • Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. HAGSTROM, J. E., SEBESTYEN, M. G., BITDKER, V., LUDTKE, J. J., FRITZ, J. D., and WOLFF, J. A., Biochim. Biophys. Acta, 1996, 1284 (1), 47–55.
  • Computered tomography of experimental liver abscesses using a new liposomal contrast agent., DICK, A., ADAM, G., TACKE, J., PRESCHER, A., SOUTHON, T. E., and GUNTHER, R. W., Invest. Radiol., 1996, 31(4), 194–203.
  • Continuum models for liposome and macromolecular drug transport in tissue. EL-KAREH, A. W., and SECOMB, T. W., BED (Am. Soc. Mech. Eng.), 1995, 29 (Proceedings of the Bioengineering Conference), 189–190.
  • Control and measurement of permeability for design of microcapsule cell delivery system. BRISSOVA, M., LACIK, I., POWERS, A. C., ANILKUMAR, A. V., and WANG, T., Polym. Propr. (Am. Chem. Soc., Div. Polym. Chem.), 1996, 37 (2), 149–150.
  • Controlled release of hCG birth control vaccine using biodegradable microspheres. GANGA, S., SINGH, 0., Proc. Int. Symp. Controlled Release Bioact, Mater., 1996, 23rd, 353–354.
  • Controlled topical delivery of cyclosporin-A from nonionic liposomal formulations. WARANUCH, N., NIEMIEC, S. M., RAMACHANDRAN, C., and WEINER, N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 327–328.
  • Decrease in endotoxin toxicity by means of liposomes. ZAKIROV, M., BURKHANOV, S. A., PETROV, A. B., and SAATOV, T. S., Dokl. Akad. Nauk. Resp. Uzb., 1995, (9–10), 59–60.
  • Delivery of CFTR gene to rabbit airways by gelatin-DNA microspheres. WALSH, S. M., FLOTTE, T. R., BECK, S., ALLEN, S., GUGGINO, W. B., AUGUST, T., and LEONG, K. W., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 73–74.
  • Design of microspheres with zero-order release profile. OKADA, J., and BABA, N., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 331–332.
  • Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. OYEN, W. J. G., BOERMAN, 0. C., STORM, G., VAN BLOOIS, L., KOENDERS, E. B., CLAESSENS, R. A. M. J., PERENBOOM, R. M., CROMMELIN, D. J. A., VAN DER MEER, J. W. M., and CORSTENS, F. H. M., J. Nucl. Med., 1996, 37 (8), 1392–1397.
  • Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques., MAYER, L. D., and ST ONCE, G. Anal. Biochem., 1995, 232 (2), 149–57.
  • Determination of liposome encapsulation efficiency of adriamycin by flocculant separation. GAO, F., ZHANG, X., WANG, L., SUN, J., and WANG, J., Shenyang Huagong Xueyuan Xuebao, 1996, 10 (2), 117–121.
  • Development and characterization of mitomycin C loaded temperature-sensitive liposomes. HOSOKAWA, T., KATo, Y., HAYAICAWA, E., and ITO, K., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 661–662.
  • Development of inherently echogenic liposomes as an ultrasonic contrast agent. ALKAN, 0. H., DEMOS, S. M., LANZA, G. M., VONESH, M. J., KLEGERMAN, M. E., KANE, B. J., KUSZAK, J., and MCPHERSON, D. D., J. Pharm. Sci., 1996, 85 (5), 486–490.
  • Diplmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. MURAMATSU, K., MAITANI, Y., and NAGAI, T., Biol. Pharm. Bull., 1996, 19 (8), 1055–1058.
  • Direct stimulation of T-lymphocyte with sialolipid-containing liposome. KATO, E., AKIYOSIII, K., and SUNAMOTO, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 641–642.
  • Direct gene transfer into living cells using fusogenic liposome. NAKAGAWA, S., MIZUGUCHI, H., NAKANISHI, M., and MAYUMI, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 893–894.
  • Disposition of free and liposomal recombinant human erythropoietin after intravenous and subcutaneous injection in rats. MORITA, H., MAITANI, Y., SHIMODA, N., and NAGAI, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 675–676.
  • Distribution of lipid microsphere preparations. IGARASHI, R., TAKENAGA, M., MATSUDA, T., Adv. Drug Delivery Rev., 1996, 20 (2, 3), 147–154.
  • Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. SAKAKIBARA, T., CHEN, F. A., KIDA, H., KUNIEDA, K., CUENCA, R. E., MARTIN, F. J., and BANKERT, R. B., Cancer Res., 1996,56 (16), 3743–3746.
  • Droplet dynamics and initial field tests for microencapsulated pesticide formulations applied at ultra low volume using rotary atomizers for control of locusts and grasshoppers. HOLLAND, J. M., and JEPSON, P. C., Pestic Sci., 1996, 48 (2), 125–134.
  • Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes. BANERJEE, G., NANDI, G., MAFIATO, S. B., PAKRASHI, A., and BASU, M. K., J. Antimicrob. Chemother., 1996, 38 (1), 145–150.
  • Effect of preparative parameters on the characteristics of poly (DL-lactide-co-glycolide) microspheres made by the double emulsion method. GHADERI, R., STURESSON, C., and CARLFORS, J., Int. y. Pharm., 1996, 141 (1, 2), 205–216.
  • Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA. CORTESI, R., ESPOSITO, E., MENEGATTI, E., GAMBARI, R., and NASTRUZZI, C., Int. J. Pharm., 139 (1, 2), 69–78.
  • Effect of lung surfactant liposomes on the rabbit fetal lung type II cell antioxidant enzymes following prenatal dexarnethasone treatment. GUPTA, A., MAJUMDAR, S., and SANYAL, S. N., Res. Exp. Med., 1996, 196 (1), 67–76.
  • Effect of liposomal composition on photoactivated liposome fusion. MILLER, C. R., BENNETT, D. E., CHANG, D. Y., and BRIEN, D. F., Biochemistry, 1996, 35 (36), 11782–11790.
  • Effect of swine serum on the stability and release of enteric vaccine microsphere. TZAN, Y. L., and LEE, C. J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 337–338.
  • Effectiveness of antifungal agent-containing microspheres for controlling oral candidiasis. SHEN, C., GRIMAUDO, N., MARSH, D., WEI, L., and BATICH, C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 517–518.
  • Effects of incorporation of lutein and 8-methoxypsoralen into erythrocyte and liposomal membranes, GAWRON, A., WOJITOWICZ, K., MISIAK, L. E., and GRUSZECKI, W. I., Pharm. Sci., 1996, 2 (2), 89–91.
  • Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of rnurine candidiasis. KRETSCHMAR, M., NICHTERLEIN, T., HANNAK, D., and HOF, H., Arzneim Forsch, 1996, 46 (7), 711–715.
  • Effects of delayed treatment with nafronyl oxalate on microsphere embolism-induced changes in monoamine levels of rat brain regions. TAKAGI, N., MIYAKE, K., OHIWA, A., NuKAGA, R., and TAKEO, S., Br. y. Pharmacol., 1996, 118 (1), 33–40.
  • Effects of membrane charges and hydroperoxides on Fen-supported lipid peroxidation in liposomes. TAMPO, Y., and YONAHA, M., Lipids, 1996, 31(10), 1029–1038.
  • Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. SALDEEN, J., CURIEL, D. T., EIZIRIK, D. L., ANDERSSON, A., STRANDELL, E., BUSCHARD, K., and WELSH, N., Diabetes, 1996, 45 (9), 1197–1203.
  • Electron microscopic study of the interaction of DC-cholesterol-containing liposomes with human erythrocytes. TARAKHOVSKII, Y. S., Byull. Eksp. Biol. Med., 1996, 122 (7), 83–86.
  • Electrophoretic mobility study of dodecyltrimethylammonium bromide in aqueous solution and adsorption on microspheres. Xu, R., and SMART, G., Langmuir, 1996, 12 (17), 4125–4133.
  • Embryotoxicity and teratogenicity studies of poly (DL-lactide-co-glycolide) microspheres incorporated tetanus toxoid in Wistar rats. CHANDRASEKARAN, R., GIRL, D. K., and CHAUDHURY, M. R., Hum. Exp. Toxicol., 1996, 15 (4), 349–351.
  • Enantioselective epoxidation using liposomized m-chloroperbenzoic acid (LIP MCPBA). KUMAR, A., and BHAKUNI, V. Tetrahedron Lett., 1996, 37 (27), 4751–4754.
  • Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Suzuxi, H., NODA, Y., GAO, X. P., SEJOURNE, F., ALKAN, 0. H., PAUL, S., and RUBINSTEIN, I. Am. y. Physiol., 1996, 271 (1 Pt 2), H282–H287.
  • Enhanced efficacy of liposomized pentamidine against experimental visceral leishmaniasis. PAL, A., AGARWAL, A., GURU, P. Y., and KATIYAR, J. C. J. Parasit. Dis., 1995, 19 (1), 45–48.
  • Enhancing effect of cholesterol on clearance of liposomes from circulation: relation to interaction with plasma proteins. ISHIDA, T., YODA, R., KOJIMA, S., FUNATO, K. and KIWADA, H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 679–680.
  • Error analysis of autoradiography method for measurement of cerebral blood flow by 1231-IMP brain SPECT: a comparison study with table look-up method and microsphere model method. ITO, H., ISHII, K., ATSUMI, H., INUICAI, Y., ABE, S., SATO, M., KINOSHITA, T., KAWASHIMA, R., ONo, S., and FUKUDA, H. Ann. Nucl. Med., 1995, 9 (4), 185–190.
  • Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. XING, D. K., MCLELLAN, K., CORBEL, M. J., and SESARDIC, D. Biologicals, 1996, 24 (1), 57–65.
  • Ethanol-enhanced permeation of phosphatidylcholine/Phosphatidylethanolamine mixed liposomal membranes due to ethanol-induced lateral phase separation. KOMATSU, H., and OKADA, S., Biochim. Biophys. Acta, 1996, 1283 (1), 73–79.
  • Europium chelate-loaded liposomes: a tool for the study of binding and integrity of liposomes. ORELLANA, A. LAUKKANEN, M. L., and KEINAENEN, K. Biochim. Biophys. Acta, 1996, 1284 (1), 29–34.
  • Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay. OKADA, N., FUSHIMI, M., NAGATA, Y., FUKUNAGA, T., TSUTSUMI, Y NAKAGAwA, S., and MAYumi, T. jpn. y. Cancer Res., 1996, 87 (9), 952–957.
  • Evaluation of microencapsulated liposome systems for hepatitis B vaccination. MACHLUF, M., APTE, R. N., KOST, J., and COHEN, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 865–866.
  • Evaluation of solvent extraction and solvent evaporation procedures for production of tobramycin-releasing microspheres. VAN HAMONT, J. E., MADDEN, E. F., WOOD, B. A., JACOB, E., and SETTERSTROM, J. A. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 365–366.
  • Evaluation of ethylcellulose microcapsules of salbutamol sulfate for sustained release. NAGARAJAN, M., GANESAN, M., and NALLURI B. N., East. Pharm., 1996, 39 (462), 123–125.
  • Experimental efficacy of targeting PEG-liposomes encapsulating amphotericin B. OTSUBO, R., KOGA, H., TANAKA, E., TAKIZAWA, T., MARUYAMA, K., and KOHNO. S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 677–678.
  • Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethy-lene glycol acid on peritoneal carcinomatosis in rats. TOKUDA, K., NATSUGOE, S., SHIMADA, M., KUMANOHOSO, T., YOSHIZAWA, H., UEMURA, Y., HATATE, Y., NAICAMUFtA, K., YAMADA, K., et al. Gan to Kagaku Ryoho, 1996, 23 (11), 1516–1518.
  • Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: efficient promoter activity of AAV sequences and in vivo delivery via liposomes. BAUDARD, M., FLOTTE, T. R., ARAN, J. M., THIERRY, A. R., PASTAN, I., PANG, M. G., KEARNS, W. G., and GOTTESMAN, M. M. Hum. Gene. Ther., 1996, 7 (11), 1309–1322.
  • Extended release of recombinant adenovirus from PLGA microspheres. HILFINGER, J. M., TSUMEE, Y., BEER, S., DAVIDSON, B., CRISON, J. R., and AMMON, G. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 915–916.
  • Factorial design-based optimization of the formulation of nitrofurantoin microcapsules. KARASULU, H. Y., ERTAN, G., and GUNERI, T., Pharm. World Sc., 1996, 18 (1), 20–25.
  • Flow-induced deformation of microcapsules. REHAGE, H., BURGER, A., LEONHARD, H., and PIEPER, G., Prog. Colloid Polym. Sci., 1996, 101 93–96.
  • Fluorescence measurement of 805 nm laser-induced release of 5,6-CF from DSPC liposomes for real-time monitoring of temperature: an in vivo study in rat liver using indocyanine green potentiation. MORDON, S., DESMETTRE, T., DEVOISSELLE, J. M., SOULIE, S. Lasers Surg. Med., 1996, 18 (3), 265–270.
  • Fluorescent probe studies of the interactions of 1-alky1-2-pyrrolidones with stratum corneum lipid liposomes. YoNEro, K., Li, S. K., Hicucm, W. I., JisicooT, W., and HERRON, J.Pharm.Sci., 1996, 85 (5), 511–517.
  • Formulation of lidocaine-PLGA microspheres for the treatment of dental pain. VAUGHAN, W. M., DuoNG, H. N., BLACKMAN, K. P., WOOD, B. A., SwrrERsTRom, J. A., VAN Hamorrr, J. E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 375–376.
  • Fusigenic viral liposome for gene therapy in cardiovascular diseases. DZAU, V. J., MANN, M. J., MORISHITA, R., KANEDA, Y. Proc. Natl. Acad. Sci. USA, 1996, 93 (21), 11421–11425.
  • Fusion of liposomes due to transient and lasting perturbation induced by synthetic amphilic peptides. ZFuto, J., KIMURA, S., and IMANISHI, Y Biochim. Biophys. Acta, 1996, 1283 (1), 37–44.
  • Gelatin Microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. ESPOSITO, E., CORTESI, R., and NAS TRUZZI, C. Biomaterials, 1996, 17 (20), 2009–2020.
  • Gene transfer with liposomes to the intraocular tissues by different routes of administration. MASUDA, I., MATSUO, T., YASUDA, T., and MATSUO, N., Invest. Ophthalmol. Vis. Sci., 1996, 37 (9), 1914–1920.
  • Gene therapy of mucoviscidosis with liposomes. LEHN, P., OUDRHIRI, N., and NAVARRO, J. Arch. Pediatre., 1996, 3 (Suppl. 1), 88s–92s.
  • Genetic immunization via mucosal and parenteral routes using microsphere carriers. ALPAR, H. 0., OZSOY, Y., BOWEN, J., EYLES, J. E., CONWAY, B. R., and WILLIAmsoN, E. D. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 861–862.
  • GM-CSF microspheres in cancer immunotherapy�a mechanistic study of the vaccine site. ZFIAO, Z., JAFFEE, E. M., THOMAS, M. C., PARDOLL, D. M., and LEONG, K. W., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 91–92.
  • GM-CSF encapsulated in PLGA microspheres for vaccine adjuvancy. PErriT, D., PANKEY, S., NIGHTLINGER, N., Dim, M., and GOMBOTZ, W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 857–858.
  • Homogeneous liposome immunoassay based on the lytic activity of phospholipase C: an assay for insulin. Lim, S. J., and KIM, C. K., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 419–420.
  • Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. DREHER, F., WALDE, P., Luis:, P. L., and ELSNER, P., Skin. Pharmacol., 1996, 9 (2), 124–129.
  • Identification of phosphatidate nonlamellar phases on liposomes by flow cytometry. BAEZA, I., AGUILAR, L., ALVAFtADO, A. F., SOTO, C., ESCOBAR, G. A., MONDFtAGON, R., GONZALEZ, S., IBANEZ, M., and WONG, C. Biochem. Cell-Biol., 1995, 73 (5-6), 289–297
  • Identification of pro-oxidant or antioxidant characteristics of proteins and enzymes in membranes; use of liposome-entrapped proteins and other thiol-containing compounds. STRAGHAN, E., SFIARMA, G., GOLDFARB, P., and WISEMAN, A. Biochem. Soc. Trans., 1996, 24(3), 375S.
  • Immune response to antigen in microspheres of different polymers. CONWAY, B. R., EYLES, J. E., and ALPAR, H. 0., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 335–336.
  • Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. BURGHAUS, P. A., WELLDE, B. T., HALL, T., RICHARDS, R. L., EGAN, A. F., RILEY, E. M., BALLou, W. R., and HOLDER, A. A. Infect. Immun., 1996, 64 (9), 3614–3619.
  • Immunization with ricin toxoid vaccine incorporated in macroporous alginate/chitosan hydrogel microspheres. KENDE, M., YAN, C., RILL, W., TAMMARIELLO, R., HELLER, J., and Liu, L. S., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 715–716.
  • Immunogenicity of infectious bovine rhinotracheitis virus (BHV-1) proteins integrated into ISCOMs or liposomes. FRANZ, J HAMPL, J., STEPANEK, J., and TEsmux, R. Vet. Med. (Praha), 1996, 41 (7), 213–218.
  • Improved stability of doxorubicin-loaded liposomes by polymer coating. TAKEUCHI, H., TOYODA, T., TOYOBUKU, H., YAMAMOTO, H., HMO, T., and KAWASHIMA, Y Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 409–410.
  • Improvement of dexamethasone dissolution rate from spray-dried chitosan microspheres. GENTA, I., PAVANETTO, F., CONTI, B., GIUNCHEDI, P., and CONTE, U., STP Pharma. Sci., 1995, 5 (3), 202–207.
  • In vitro biodegradation of poly(.beta.-hydroxybutyrate-hydroxyvalerate) microspheres exposed to Hanks' buffer, newborn calf serum, pancreatin and synthetic gastric juice. ATKINS, R. W., and PEACOCK, S. J., 5. Biomater. Sci., Polym. Ed., 1996, 7 (12), 1075–1084.
  • In vivo activity of cisplatin microspheres incorporated with polylactic acid and polyethylene glycol acid. TOKUDA, K., NATSUGOE, S., SHIMADA, M., KUMANOHOSO, T., YOSHIZAWA, H., UEMURA, Y., HATATE, Y., NAKAMURA, K., YAMADA, K., et al., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 385–386.
  • In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cells. I'm', K., TABATA, C. Y., IKE, 0., SHIMIIZU, Y., KUWABARA, M., KYO, M., HYON, S. H., and IKADA, Y., J. Controlled Release, 1996, 42 (2), 175–184.
  • In vivo immunizations to monkeys of human T-cell leukemia virus type I related protein reconstituted into mannan coating liposomes. KOBAYASHI, H., SATO, S., SAIGA, A., ORITA, S., TSUCHIYA, E., INAGAKI, H., YAMASHITA, T., and IGARASHI, H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 863–864.
  • In vitro-in vivo myotoxicity of intramuscular liposomal formulations. AL SUWAYEH, S. A., TEBBETT, I. R., WIELBO, D. and BRAZEAU, G. A., Pharm. Res., 1996, 13 (9), 1384–1388.
  • Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. ARAB, S., and LINGWOOD, C. A., Glycoconj. y., 1996, 13 (2), 159–166.
  • Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. PHILLIPS, N. C., GAGNE, L., IVANOFF, N., and RIVEAU, G., Vaccine, 1996, 14 (9), 898–904.
  • Informational liposomes: complexes derived from cholesteryl-conjugated oligonucleotides and liposomes. ZHANG, G., FAROOQUI, F., KISTLER, 0., and LETSINGER, R. L., Tetrahedron Lett., 1996, 37 (35), 6243–6246.
  • Inhibition of liposomal lipid peroxidation by isoflavonoid type phytoestrogens from soybeans of different countries of origin. WISEMAN, H., Lim, P., and O'REILLY, J Biochem. Soc. Trans., 1996, 24 (3), 392S.
  • Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. SUGAYA, S., FUJITA, K., KIKUCHI, A., UEDA, H., TAICAKUWA, K., KODAMA, S., and TANAKA, K., Hum. Gene. Ther., 1996, 7 (2), 223–230.
  • Innovative approaches for the stabilization and controlled release of tetanus vaccine from polyester microspheres. ALONSO, M. J., VILLAMAYOR, B., TOBIO, M., SCHWENDEMAN, S., GUPTA, R. K., SIBER, G., and LANGER, R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 825–826.
  • Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes. SHIN, I., SILMAN, I., and WEINER, L. M., Protein Sci., 1996, 5 (1), 42–51.
  • Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadia-zine: proof of the uptake of intact vesicles. SCHALLER, M., KORTING, H. C., and SCHMID. M. H., Br. y. Dermatol., 1996, 134 (3), 445–450.
  • Interaction of sugar with phospholipid bilayer-study on the stabilization of liposomes. TONG, Q., and NIE, S., Shengli Kexue jinzhan, 1996, 27 (2), 123–128.
  • Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis., JANZEN, J., SONG, X., and BROOKS, D. E., Biophys. y., 1996, 70 (1), 313–320.
  • Internal morphology of biodegradable BCNU-loaded microspheres. BENOIT, J. P., PAINBENI, T., and VENIER, J. M. C., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 379–380.
  • Intracranial delivery of interleukin-2 by microspheres in the treatment of brain tumors. SILLS, A. K., ZHAO, Z., VAN WESSEM, K., CRONGEYER, J., TYLER, B., EWEND, M. G., LEONG, K., and BREM, H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 855–856.
  • Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. YAN, C., RILL, W. L., MALLI, R., HEWETSON, J., NASEEM, H., TAMMARIELLO, R., and KENDE, M., Vaccine, 1996, 14 (11), 1031–1038.
  • Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. KITAMURA, I., KOCHI, M., MATSUMOTO, Y., UEOKA, R., KURATSU, J., and UsHio, Y., Cancer Res., 1996, 56 (17), 3986–3992.
  • Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. SUNTRES, Z. E., and SHEK, P. N., Biomed. Environ. Sci., 1995, 8 (4), 289–300.
  • Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. HUSAIN, D., MILLER, J. W., Mictukun, N., CONNOLLY, E., FLOTTE, T. J., and GRADOUDAS, E. S. Arch. Ophthalmol. (Chicago), 1996, 114 (8), 978–985.
  • Kinetics of association processes of D-fructose dehydrogenase onto liposome surfaces. KAKINOKI, K., MAEDA, Y., HASEGAWA, K., and KITANO, H., Polym. Bull. (Berlin), 1996, 37 (3), 407–414.
  • Kinetics of cytokine gene expression in macrophage and endothelial cell lines following liposome encapsulated Hb (LEH) treatment in vitro. Ziiu, X. L., GAFNEY, W. C. M., PACHECO, N. D., and ROLLWAGEN, F. M. Cytokine, 1996, 8 (7), 541–547.
  • Lectin-bearing polymerized liposomes as potential oral vaccine carriers. CHENG, H., TORCHILIN, V., and LANCER, R., Pharm. Res., 1996, 13 (9), 1378–1383.
  • Limethason as a lipid microsphere preparation: an overview. YOKOYAMA, K., and WATANABE, M., Adv. Drug Delivery Rev., 1996, 20(2, 3), 195–201.
  • Lipid microsphere preparation of a prostacyclin analog. KUROZUMI, S., ARAKI, H., TANABE, H., and KIYOKI, M. Adv. Drug Delivery Rev., 1996, 20 (2, 3), 181–187.
  • Lipid microspheres (lipid emulsions) as a drug carrier-an overview. MizusrumA, Y. Adv. Drug Delivery Rev., 1996, 20 (2, 3), 113–115.
  • Lipid microspheres as drug carriers: a pharmaceutical point of view. YAMAGUCHI, T., Adv. Drug Delivery Rev., 1996, 20 (2, 3), 117–130.
  • Lipo-PGE1, prostaglandin El incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion. EGASHIRA, T., KIM, Y. I., TAKAYAMA, F., KUDO, Y., YAMANAICA, Y. Free Radical Biol. Med., 1996, 21(3), 353–356.
  • Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis. LEENDERS, A. C. A. P., DE MARIE, S., TEN KATE, M. T., BAKKER WOUDENBERG, I. A. J. M. and VERBRUGH, H. A., J. Antimicrob. Chemother., 1996, 38 (2), 215–225.
  • Liposomal delivery of interleukin-2 in locoregional anticancer immunotherapy. STORM, G., KOPPENHAGEN, F. J., STEERENBERG, P. A., DEN OTTER, W., and CROMMELIN, D. J. A., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 95–96.
  • Liposomal formulations with soybean-derived stearyl glucoside for targeting to hepatocytes. Srumizu, K., MAITANI, Y., TAKAYAMA, K., and NAGAI, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 685–686.
  • Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS. ARAMAKI, Y., ARIMA, H., TOSHIFUMI, H., and TSUCHIYA, S., Pharm. Res., 1996, 13 (9), 1389–1392.
  • Liposomal trafficking in normal and tumor-bearing mice determined by use of positron emission tomography. Oicu, N., TOKUDOME, Y., TsuKADA, H., NAMBA, Y., and OKADA, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 93–94.
  • Liposomal encapsulation of doxorubicin. LIAO, C. E., YIN, S. L., CHEN, G. M., and LEE, S. W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 687–688.
  • Liposomal etoposide: characterization and in vitro release. KUMAR, K., SISTLA, A., and KOBRINSKY, OBRINSKY. L., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 405-406. Liposomal formulation of mirfentanil hyrochloride. BETAGERI, G. V., SEGERS, J., SPAULDING, T. C., PEJAVER, S. K., and BRITTAIN, H. G., FDA J. Pharm. Sci. Technol., 1996, 50 (4), 219-222. Liposomal formulations of ABT-077: In vitro characterization studies. Gurra, P., CANNON, J., and ADJEI, A., Int. y. Pharm., 1996, 140(1), 119–129.
  • Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity. RICFIARDS, R. L., ALVING, C. R., and WASSEF, N. M. J. Pharm. Sc., 1996, 85 (12), 1286–1289.
  • Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. MEHTA, R. T., Antimicrob. Agents Chemother., 1996, 40 (8), 1893–1902.
  • Liposome-based gene transfer vehicles. SULLIVAN, S. M., BioPharm. (Eugene, Oreg.), 1996, 9 (8), 50–51. 65–66.
  • Liposome-based gene transfer vehicles. SULLIVAN, S. M., Pharm. Technol., 1996, 20 (10), 34, 36, 40, 42.
  • Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. NAITO, M., NAGAI, H., KAWANO, S., UMEZU, H., ZHU, H., MORIYAMA, H., YAMAMOTO, T., TAKATSUICA, H., and TAKE, Y., J. Leukocyte Biol., 1996, 60 (3), 337–344.
  • Liposomes bearing platelet proteins: a model for surface function studies. DALENCON, F., Rosum, V., PUISIEUX, F., BASZKIN, A., and WAUTIER, J. Luc. Biochim. Biophys. Acta, 1996, 1302 (3), 241–248.
  • Liposomes as an agrochemical tool: optimization of their production. PONS, M., and ESTELRICH, J., Ind. Crops Prod., 1996, 5 (3), 203–208.
  • Liposomes as delivery agents for medical imaging. TORCHILIN, V. P., Mol. Med. Today, 1996, 2 (6), 242–249.
  • Liposomes in cosmetic formulations. Exploring methods for determining the presence, and quality of unilamellar liposomes in products. BURMEISTER, F., BENNETT, S., and BROOKS, G., Cosmet. Toiletries, 1996, 111 (9), 49–50. 52–53.
  • Liposomes in gene therapy. LAsic, D. D., and TEMPLETON, N. S., Adv. Drug Delivery Rev., 1996, 20 (2, 3), 221–266.
  • Long-term amelioration of rat adjuvant arthritis following systemic elimination of macro-phages by clodronate-containing liposomes. KINNE, R. W., SCHMIDT, W. C. B., HOPPE, R., BUCHNER, E., PALomEo, K. E., NURNBERG, E., and EMMRICH, F., Arthritis. Rheum., 1995, 38 (12), 1777–1790.
  • Long-term expression of the human alphal-antitrypsin gene in mice employing anionic and cationic liposome vectors. CREPSO, J., BLAYA, C., CRESPO, A., and ALINo, S. F., Biochem. Pharmacol., 1996, 51(10), 1309–1314.
  • Lyophilization and rehydration of iopromide-carrying liposomes. ZINGEL, C., SACHSE, A., ROESSLING, G. L., and MUELLER, R. H., Int. y. Pharm., 1996, 140 (1), 13–24.
  • Massage-induced delivery of subcutaneously-injected liposome-encapsulated drugs into the blood. TRUBETSKOY, V. S., TORCHILIN, V. P., and WOLF, G. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 403–404.
  • Measurement of optic nerve blood flow with nonradioactive colored microspheres in rabbits. ORGUL, S., CIOF, G. A., BACON, D. R., BHANDARI, A., and VAN BUSKIRK, E. M., Microvasc. Res., 1996, 51(2), 175–186.
  • Mechanical properties of microcapsules. BOROVKOV, N. Y., MORYGANOV, A. P., and SIBRINA, G. V. Zh. Prikl. Khim. (S-Peterburg), 1996, 69 (4), 678–683.
  • Mechanism of oligonucleotide release from cationic liposomes. ZELPHATI, 0. and SzoKA, F. C. JR. Proc. Natl. Acad. Sci. USA, 1996, 93 (21), 11493–11498.
  • Microencapsulated hepatocytes as a component of a bioartificial liver. DIXIT, V., BIGGINS, S., and GITNICK, G., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 8–9.
  • Microencapsulation of sulfadiazine by water/oil/water complex emulsion technique. KONDO, T., HAFEZ, E., ABDEL, M. H., MURAMATSU, N., EL HARRAS, S., and EL GIBALY, I., Pharm. Ind., 1996, 58 (6), 552–556.
  • Microencapsulation in polyurea shell: kinetics and film structure. YADAV, S. K., KHILAR, K. C., and SURESH, A. K., AIChE Y., 1996, 42 (9), 2616–2626.
  • Microsphere distribution in the pancreas of anesthetized rats. Alloxan stimulates the blood flow to all islets whereas glucose only affects the blood perfusion of a subgroup of islets. JANSSON, L., Int. y. Pancreatol., 1996, 20(1), 69–74.
  • Modification of antibodies with alkyl glycidyl phosphate and preparation of antibody-bearing liposomes. SONG, X. M., NAICAMURA, M., YAMAMOTO, T., KUROSAKI, T., and Tsum, K., Nihon Yukagakkaishi, 1996, 45 (8), 747–754.
  • Modulation of cationic liposomal DNA zero potential and liposome-protein interaction by amphiphilic poly(ethylene glycol). PHILLIPS, N. C., and HEYDARI, C., Pharm. Sci., 1996, 2 (2), 73–76.
  • Moessbauer study of potassium ferrocyanide and ammonium ferric alum crystallization from aqueous solutions in microcapsules. ASRAKHOV, N. V., STEL, M. I. V., and KAPSUTIN, M. G., Inorg. Mater. (Transl. of Neorg. Mater.), 1996, 32 (10), 1098–1101.
  • Morphology of cationic liposome/DNA complexes in relation to their chemical composition. STERNBERG, B., J. Liposome Res., 1996, 6 (3), 515–533.
  • Mucoadhesive liposomes bearing metronidazole for controlled and localized vaginal delivery. JAIN, S. K., SINGH, R., and JAIN, V. V., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 701–702.
  • Multivalent ligand system carrying enkephalin and neurotens'in coimmobilized on liposomes. ZHAo, J., KIMURA, S., and ImANIsm, Y., J. Pept. Sci., 1996, 2 (4), 245–251.
  • Neuroprotective effect of ITC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone spontaneously hypertensive rats. YAMASHITA, K., KATAOKA, Y NAKASHIMA, M., YAMASHITA, Y., TANABE, H., ARAKI, H., NIWA, M., and TANIYAMA, K., ypn. y. Pharmacol., 1996, 71(4), 351–355.
  • Nonporous silica microspheres in the micron and submicron size range: manufacture, characterization and application. KAISER, C., HANSON, M., GIESCHE, H., KINKEL, J., UNGER, K. K., NATO ASI Ser, Ser 3, 1996, 12 71–84.
  • Nonswellable and swellable poly(EGDMA) microspheres. TUNCEL, A., and PISKIN, E., J. Appl. Polym. Sci., 1996, 62 (5), 789–798.
  • Normal CBF values by the ARG method using IMP SPECT: comparison with a conventional rnicrosphere model method. ITo, H., ISHII, K., KINOSHITA, T., KOYAMA, M., KAWASHIMA, R., ONO, S., and FUKUDA, H., Kaku. Igaku., 1996, 33 (2), 175–178.
  • Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. SUN, Y., MA, X., ZHOU, D., VACEK, I., and SUN, A. M., J. Clin. Invest., 1996, 98 (6), 1417–1422.
  • Novel strategy of gene therapy in cardiovascular disease with HVFliposome method. MORISHITA, R., HIGAKI, J., AOKI, M., HAYASHI, S., KIDA, I., KANEDA, Y., and OGTHARA, T., Cont rib. Nephrol., 1996, 118, 254–64.
  • Novel microencapsulation technique for controlled release of a water-soluble non-basic drug. TAKADA, S., KUROKAWA, T., MIYAZAKI, K., IwAsA, S., and OGAWA, Y., Proc. Int. Symp. Controlled Release Biact. Mater., 1996, 23rd, 339–340.
  • Novel pH-sensitive liposomes: preparation of liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups and their application to drug delivery systems. KONO, K., IGAwA, T., and TAKAGISHI, T., Front. Biomed. Biotechnol., 1996, 3, 181–192.
  • Novel, burst free, programmable biodegradable microspheres for controlled release of polypeptides. JEYANTHI, R., AKIYAMA, A., FRIDEN, P., ROBERTS, F. D., VAN HAMONT, J., REID, R., and MCQUEEN, C., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 351–352.
  • Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system. KASE, R., BIERFREUND, U., KLEIN, A., KOLTER, T., Prox, K., Suzum, M., HASHIMOTO, Y., SANDHOFF, K., and SAKURABA, H., FEBS Lett., 1996, 393 (1), 74–76.
  • Optimization of the formulation design of chitosan microspheres containing cisplatin. WANG, Y. M., SATO, H., ADACHI, I., HORIKOSHI, I., J. Pharm. Sci., 1996, 85 (11), 1204–1210.
  • Optimized preparation of poly(DL-lactide-co-glycolide) microspheres and nanoparticles for oral administration. CHACON, M., BERGES, L., MOLPECERES, J., ABERTURAS, M. R., and GUZMAN, M., Int. y. Pharm., 1996, 141 (1, 2), 81–91.
  • Ordered arrangement in binary mixture of polymer microspheres. TOKUSHIGE, K., KAWAHARA, K., and FUKUTOMI, T., Polym. y. (Tokyo), 1996, 28 (8), 665–670.
  • Oxidation of alpha-tocopherol during the peroxidation of dilinoleoylphosphatidylcholine in liposomes. YAMAUCHI, R., YAM, Y., and 1CATo, K., Biosci. Biotechnol. Biochem., 1996, 60 (4), 616–620.
  • Paramagnetic polymerized liposomes as new recirculating MR contrast agents. STORRS, R. W., TROPPER, F. D., LI, H. Y., SONG, C. K., SIPKINS, D. A., KUNIYOSHI, J. K., BEDNARSKI, M. D., STRAUSS, H. W., and Li, K. C. 5. Magn. Reson. Imaging, 1995, 5 (6), 719–724.
  • Partial fusion activity of influenza virus toward liposomes and erythrocyte ghosts is distinct from viral inactivation. RAMALHO, S. J., PEDROSO, DE L. M. C., and NIR, S., 5. Biol. Chem., 1996, 271 (39), 23902–23906.
  • Participation of cholesterol in hypochlorite-induced oxidation of cholesterol-phosphatidyl-choline liposomes. MOMYNALIEV, K. T., GOVORUN, V. M., PANASENKO, 0. N., and SERGIENKO, V. I., Byull. Eksp. Biol. Med., 1996, 121 (5), 515–519.
  • Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Ho, S., LAG, W. Y., LEUNG, T. W., CHAN, M., NGAR, Y. K., JOHNSON, P. J., LI, A. K., Eur. 5. Nucl. Med., 1996, 23 (8), 947–952.
  • PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice. VAN DEVENTER, A. J., GOESSENS, W. H., VAN BELKUM, A., VAN ETTEN, E. W., VAN VLIET, H. J., and VERBRUGH, H. A., 5. Clin. Microbiol.� 1996, 34 (1), 25–28.
  • Peptide containing microspheres from low molecular weight and hydrophilic poly(d, 1-lactide-co-glycolide). MEHTA, R. C., THANOO, B. C., and DELucA, P. P., 5. Controlled Release, 1996, 41 (3), 249–257.
  • Percutaneous penetration of liposomes using the tape stripping technique. CODERCH, L., OuvA, M., PONS, M., MAZA, A. DE LA, MANICH, A. M., and PARRA, J. L., mt. y. Pharm., 1996, 139 (1, 2), 197–203.
  • Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. OKADA, H., DOKEN, Y., and OGAWA, Y., 5. Pharm. Sci., 1996, 85 (10), 1044–1048.
  • Pharmacodynamics after intravenous administration of liposomal insulin. KIM, A., KIM, K. M., and Kim, C. K., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 885–886.
  • Pharmacokinetic rationale for chemotherapeutic drugs combined with intra-arterial degradable starch microspheres (Spherex). JOHANSSON, C. J., Clin. Pharmacokinet., 1996, 31(3), 231–240.
  • Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. WEN, H., NEW, R. R. C., MUHMUT, M., WANG, J. H., WANG, Y. H., ZHANG, J. H., SHAO, Y. M., and CRAIG, P. S., Parasitology, 1996, 113 (2), 111–121.
  • Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. DIEDERICHS, J. E., Electrophoresis, 1996, 17 (3), 607–611.
  • Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolization. CROOK, K., MCLACHLAN, G., STEVENSON, B. J., and PoRTRoos, D. J., Gene. Ther., 1996, 3 (9), 834–839.
  • Platelet adherence to expanded-polytetrafluoroethylene grafts containing embedded microspheres. RICHEY, T., and HARRIS, F. W., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 391–392.
  • Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. ERTL, H. C. J., VARGA, I., XIANG, Z. Q., KAISER, K., STEPHENS, L., and OTVOS, L. JR., Vaccine, 1996, 14 (9), 879–885.
  • Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems. CHICKERING, D., JAcos, J., and MATinowiTz, E., Biotechnol. Bioeng., 1996, 52 (1), 96–101.
  • Poly(lactide-co-glycolide) microencapsulation of vaccine antigens. JONES, D. H., MCBRIDE, B. W., and FARRAR, G. H., Y. Biotechnol., 1996, 44 (1–3), 29–36.
  • Polymers toughened with rubber microspheres: an analytical solution for stresses and strains in the rubber particles at equilibrium and rupture. FOND, C., LOBBRECHT, A., and SCHIRRER, R., Int. y. Fract., 1996, 77 (2), 141–159.
  • Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. ELJASCHEWITSCH, J., SANDFORT, J., TINTELNOT, K., HORBACH, I., and RUF, B., Mycoses, 1996, 39 (3-4), 115–119.
  • Preoperative lymph-node staining with liposomes containing patent blue violet. A clinical case report. PUMP, B., and HIRNLE, P., y. Pharm. Pharmacol., 1996, 48 (7), 699–701.
  • Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation. ZEISIG, R., FUE, I., KOSCH, M., FICHTNER, I., and ARNDT, D., Biochim. Biophys. Acta, 1996, 1283 (2), 177–184.
  • Preparation and characterization of poly(adipic anhydride) microspheres for ocular drug delivery. ALBERTSSON, A. C., CARLFORS, J., and STURESSON, C., J. Appl. Polym. Sci., 1996, 62 (4), 695–705.
  • Preparation and characterization of hydrophobic PLG microspheres suitable for oral vaccination with rotavirus. STURESSON, C., ARTURSSON, P., SVENSSON, L., and CARLFORS, J., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 515–516.
  • Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. WANG, Y. M., SATO, H., ADACHI, I., and HORIKOSHI, I. Chem. Pharm. Bull., 1996, 44 (10), 1935–1940.
  • Preparation and characterization of polymer microspheres which have specific binding ability for saccharide molecules. TSUKAGOSHI, K., KAWASAKI, R., MAEDA, M., TAKAGI, M., Anal. Sci., 1996, 12 (5), 721–726.
  • Preparation and evaluation of zidovudine-loaded sustained-release microspheres. 2. Opti-mization of multiple response variables. ABU, I. K., GARCIA, C. L., Lu, D. R., y. Pharm. Sci., 1996, 85 (6), 572–576.
  • Preparation and evaluation of microencapsulated sulfadiazine resin complex. KONDO, T., HAFEZ, E., ABDEL, M. H., MURAMATSU, N., EL HARAS, S., and EL GIBALy, I., Powder Technol., 1996, 88 (2), 101–105.
  • Preparation and pharmacokinetic evaluation of a new injectable microcapsule of levonorgestrel. CONG, H., GAO, Z., GAO, Y., Li, R., Li, W., Liu, L., Yu, J, ZHANG, F., Liu, F., and Qi, H., Shengzhi Yu Biyun, 1996, 16 (2), 141–146.
  • Preparation and structural characteristics of stimuli-responsive hydrogel microsphere. NAKAZAWA, Y., KAMIJO, Y FuJimoTo, K., KAWAGUCHI, H., YUGUCHI, Y., URAKAWA, H., and KAJIWARA, K., Angew Makromol. Chem., 1996, 240, 187–196.
  • Preparation by spray drying of microcapsules with a core of a water soluble substance and a shell of ethylcellulose. YAMADA, N., NAKAMURA, H., and ABE, E., Funtai Kogaku Kaishi, 1996, 33 (8), 632–637.
  • Preparation of gelling microspheres of acebutolol hydrochloride by powder coating with sodium alginate in the polymeric spherical crystallization system. Cm, F., KAWASHIMA, Y., TAKEUCHI, H., NIWA, T., and HINO, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 345–346.
  • Preparation of a large colored microsphere with carboxyl groups for cell surface labeling. ZHAO, X., Liu, Y., Hui, H., and Wu, D., Disi junyi Daxue Xuebao, 1996, 17 (4), 245–247.
  • Preparation of carbon-free gel-microspheres suitable for fabrication of high density U05 pellets. SURYANARAYANA, S., KUMAR, N., BAMANKAR, Y. R., VAIDYA, V. N., and SOOD, D. D., Trans. Powder Metall. Assoc. India, 1995, 22, 30–34
  • Preparation and evaluation of pH-sensitive long-circulating liposomes entrapped methotrexate. HONG, M. S., and Kim, C. K., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 923–924.
  • Preparation of vitamins E and C liposomes with lecithin by ultrasound and emulsion method. LIANG, Y. Z., and BAo, L., Riyong Huaxue Gongye, 1994, (4), 171–174.
  • Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. BAau, J. S., NAIR, S., KANDA, P., and ROUSE, B. T., Vaccine, 1995, 13 (17), 1669–1676.
  • Protection of a model protein, lactate dehydrogenase, by encapsulation in liposome. NEMA, S., and Avis, K. E., PDA J. Pharm. Sci. Technol., 1996, 50 (4), 213–218.
  • Protein release from microspheres of star-shaped PEO-PLA block copolymers. Cnoi, Y. K., BAR, Y. H., and Kim, S. W., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 349–350.
  • Quantifying brain tumor blood flow by the microsphere model with N-isopropyl-p-(123I) iodoamphetamine super-early SPECT. NAMBA, H., YANAGISAWA, M., Yui, N., TOGAWA, T., KINOSHITA, F., IWADATE, Y., and SUEYOSHI, K., Ann. Nucl. Med., 1996, 10 (1), 161–164.
  • Randomized cross-over comparison of liposomal daurtorubicin versus observation for early Kaposi's sarcoma. UTHAYAKUMAR, S., BOWER, M., MONEY, K. J., MUYSHONDT, C., YOULE, M., HANNON, F., PHILLIPS, R., GAZZARD, B. G., and BoAG, F., AIDS, 1996, 10 (5), 515–519.
  • Release of influenza vaccine from biodegradable microspheres and microencapsulated liposomes. HILBERT, A., KISSEL, T., FRITZSCHE, U., and REERS, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 79–80.
  • Release kinetics of liposomal tetracaine. PENA, M., LAIRION, F., NACUCCHIO, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 663–664.
  • Renal pathology after arterial yttrium-90 microsphere administration in pigs. A model for superselective radioembolization therapy. ZIMMERMANN, A., SCHUBIGER, P. A., METTLER, D., GEIGER, L., TRILLER, J., and ROSLER, H., Invest. Radiol., 1995, 30 (12), 716–723.
  • Retrograde fluorescent microsphere tracing of retinal and central afferents to the nucleus of the optic tract in pigmented and albino rats. AARNOUTSE, E. J., VAN DER WANT, J. J., and VRENSEN, G. F., Neurosci. Lett., 1995, 201 (2), 143–146.
  • Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporo-zoite protein vaccine encapsulated in liposomes. HEPPNER, D. G., GORDON, D. M., GROSS, M., WELLDE, B., LEITNER, W., KRZYCH, U., SCHNEIDER, I., WIRTZ, R. A., RICHARDS, R. L., et al. y. Infect. Dis., 1996, 174 (2), 361–366.
  • Sandostatin LAB (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmocodynamic relationships. GRASS, P., MARBACH, P., BRUNS, C., and LANCRANJAN, I., Metab., Clin. Exp., 1996, 44 (8, Suppl. 1), 27–30.
  • Selective liver sinusoidal antitumor lymphocyte potentiation and hepatic tumor metastasis inhibition effects of galactose moiety-modified liposome interleukin-2. NAKAMURA, K., Oxulgo, K., and TANAKA, A., Kinki Daigaku Igaku Zasshi, 1996, 21(1), 125–135.
  • Sensitization of nude mice using direct liposome transfer of tumor cell antigens. ARIYASU, T., IKE, 0., HITOMI, S., WADA, H., OKUMURA, Y., and SUNAMOTO, J., y. Bioact. Compat. Polym., 1996, 11 (3), 191–202.
  • Simulation study on the optimization of antitumor effect of liposomally encapsulated doxorubicin based on the physiological model with cell kill kinetic model. ImA, S., URAICAMI, Y., HARASHIMA, H., and KIWADA, H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 653–654.
  • Simulation study on the prediction of optimum release rate of antitumor drugs from liposomes based on the physiological model with cell kill kinetic model. IIDA, S., URAICAMI, Y., HARASHIMA, H., and KiwADA, H., Yakubutsu Dotai, 1996, 11 (Suppl.), S100–S101.
  • Size fractionation of gas-filled microspheres by flotation. KVALE, S., JAKOBSEN, H. A., ASBJOERNSEN, 0. A., and OmTvEIT, T., Sep. Technol., 1996, 6 (4), 219–226.
  • Sodium ion translocation by N5-methyltetrahydromethanopterin: coenzyme M methyltrans-ferase from Methanosarcina mazei Gol reconstituted in ether lipid liposomes. LIENARD, T., BECHER, B., IVIAascpuku., M., BOWIEN, S., and GOTTSCHALK, G., Eur. y. Biochem., 1996, 239 (3), 857–864.
  • Some observations on the solvent extraction and drying characteristics of PLGA microspheres. CHERN, R. T., WILSON, R. A., TANG, J., and ZHAO, Z., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 363–364.
  • Specific serological response by active immunization with GD3-bearing liposomes. MASSO, 0., ALINO, S. F., LEJARRETA, M., BLASCO, F., and PIULATS, J., J. Pharmacol. Exp. Ther., 1996, 278 (3), 1114–1120.
  • Stability of dry liposomes in sugar glasses. SUN, W. Q., LEOPOLD, A. C., CROWE, L. M., and CROWE, J. H., Biophys. y., 1996, 70(4), 1769–1776.
  • Stearylamine liposome as a new efficient reagent for DNA transfection of eukaryotic cells. WANG, ANG., JiNG, N., and LIN, Q., Biochem. Biophys. Res. Commun., 1996, 226 (2), 450-455. Sterically stabilized liposomes as drug delivery systems for biotechnology therapeutics. WOODLE, OODLE. C., BioPharm. (Eugene, Oreg.), 1996, 9 (8), 46–49.
  • Striatal transplants of microencapsulated bovine chromaffin cells reduces rotational behavior in the rat model of parkinsonism. TSANG, P. W., KWAN, H. C., and SUN, A. M., Proc. hit. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 6–7.
  • Studies on gelatin microsphere loaded ligustrazine hydrochloride for lung targeting. ZENG, F. B., Lu, B., YANG, H., and DENG, X. X., Yao, Hsueh. Hsueh. Pao., 1996, 31(2), 132–137. Studies on perfume microcapsules. Zou, Z., ZHANG, J., QIAN, J., and MA, Q., Riyong Huaxue Gongue, 1996, (2), 14–17.
  • Subconjunctival 5-fluorouracil polyphase liposome interference with scar formation in experimental filtration surgery. Juvo, M., Xi, S., and CHEN, R., Chung. Hua. Yen. Ko. Tsa. Chih., 1996, 32 (1), 49–52.
  • Superiority of liposomal amikacin? A comparison with free drug admixed to colloidal carriers. DIEDERICHS, J. E., LEITZKE, S., BUCKE, W. E., BORNER, K., HAHN, H., MUELLER, R. H., and EHLERS, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 659–660.
  • Surface-contact mechanics during oblique impact of microspheres with planar surfaces. DUNN, P. F., BRACH, R. M., and JANSON, G. G., Aerosol. Sci. Technol., 1996, 25 (4), 445–465.
  • Synthesis and properties of bioerodible latexes and microspheres. SLomKowsKi, S., SOSNOWSKI, S., and GADZINOWSKI, M. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1996, 37 (2), 135-136. Synthesis of polymer microspheres with polypyrrole core. Ismzu, K., HONDA, K., SAITO, R., Polymer., 1996, 37 (17), 3965–3970.
  • Temperature-controlled release and fusion of liposomes bearing poly(n-isopropylacryl-amide). KONO, K., HAYASHI, H., and TAKAGISHI, T., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 783–784.
  • Testing protein-walled microcapsules for the rearing of first-feeding gilthead sea bream (Sparus aurata L.) larvae. YUFERA, M., SARASQUETE, M. C., and FERNANDEZ, D. C., Mar. Freshwater Res., 1996, 47 (2), 211–216.
  • The effect of monovalent and divalent cations on sterically stabilized phospholipid vesicles (liposomes). KOSTARELOS, K., TADROS, T. F., and LucicHam, P. F., Prog. Colloid. Polym. Sci., 1996, 100, 206–211.
  • The use of liposomal ionophores as potentiators of ricin A immunotoxins for cancer chemotherapy. SINGH, M., STEMBRIDGE, N., and BENNEFIELD, S., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 407–408.
  • The effect of polymer blending or coating on the preparation of alginate microspheres containing a hydrophilic beta-lactam antibiotic. CHUN, K. H., KWON, I. C., KIM, Y. H., SOHN, Y. T., and JEONG, S. Y., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 343–344.
  • The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro. MAKKONEN, N., HIRVONEN, M. R., SAVOLAINEN, K., LAPINJOKI, S., and MONKKONEN, J., Inflamm. Res., 1995, 44 (12), 523–528.
  • The experimental study of Chansu liposome on murine orthotopically transplanted with bladder cancer. TIAN, P., NA, X., ZHANG, X., and WENG, G., Xi'an Yike Daxue Xuebao, 1996, 17 (1), 12–15.
  • The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II) microencapsulated CSF-1 and LM-10 cells as delivery systems. MAYSINGER, D., BEREZOVSKAYA, 0., and FEDOROFF, S., Exp. Neurol., 1996, 141 (1), 47–56.
  • The incorporation and release of bovine serum albumin from poly (beta-hydroxybutyrate-hydroxyvalerate) microspheres. ATKINS, T. W., and PEACOCK, S. J., J. Biomater. Sci., Polym. Ed., 1996, 7 (12), 1065–1073.
  • The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature. SANDERSON, N. M., Guo, B., JACOB, A. E., HANDLEY, P. S., CUNNIFFE, J. G., and JONES, M. N. Biochim. Biophys. Acta, 1996, 1283 (2), 207–214.
  • The preparation of norfloxacin-loaded liposomes and their in vitro evaluation in pig's eye. Los, H. H., Ko, S. M., Hsu, L. R., and TSAI, Y. H. J. Pharm. Pharmacol., 1996, 48 (8), 801–805.
  • The effect of dose on the intracellular fate of liposomes. YOSHIMURA, K., MORIOKA, Y., HARASHIMA, H., and KIWADA, H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 683–684.
  • The possibility of the use of microcapsules with gelatin-based shells as a releasing system. BOROVKOV, N. Y., SIBRINA, G. V., and ZHELEZNOV, K. N., Izv. Vyssh. Uchebn. Zaved, Khim. Khim. Teknol., 1996, 39 (1/2), 58–61.
  • The use of coloured dye-extraction microspheres to measure blood flow in rabbit f..-keletal muscle: a validation study with special emphasis on repeated measurements. DEGENS, H., CRAVEN, A. J., JAKvis, J. C., and SALMONS, S., Exp. Physiol., 1996, 81(2), 239–249.
  • Theoretical considerations on self-similarity of the polyethylene glycol-coated liposomal surface. HOOP, B., and TORCHILIN, V. P., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 785–786.
  • Three-dimensional networks of liposomes: preparation and electron microscopical characterization. BRANDL, M., DRECHSLER, M., BACHMANN, D., and BAUER, K. H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 25–26.
  • Three-dimensional networks of liposomes: change of properties upon autoclaving. TARDI, C., DRECHSLER, M., SCHUBERT, R., and BRANDL, M., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 27–28.
  • Transcytosis of lipid microspheres by human endothelial cells. TAKAHASHI, K., Suzum, K., ICHIKI, Y., FUKUSHIMA, T., NAKAMURA, H., and SAWASAKI, Y., Pharmacology, 1996, 53 (1), 37–47.
  • Treatment of malignant pleural effusions using cisplatin-containing bioresorbable microspheres. IKE, 0., HYON, S. H., HITOMI, S., WADA, H., IKADA, Y., and SHIMIZU, Y., Proc. Int. Symp. Controlled Release Bioact. Mater., 1996, 23rd, 383–384.
  • Triterpenes from Betula pendula decrease liposome stability, are hemolytic, and inhibit hepatorna cell growth. TAIPALE, H. T., SUHONEN, T. M., KARENLAMPI, S. 0., and LAPINJOKI, S. P., Nat. Prod. Lett., 1995, 6 (1), 69–75.
  • Trypanocidal value of liposomal diminazene in experimental Trypanosoma brucei evansi infection in mice. YONGSHENG, Y., YONGCHUN, 0., CHENGMAI, R., YUANGUO, C., and FENQIN, Z. Vet. Parasitol., 1996, 61 (3-4), 349–352.
  • Two alternatives. Lipase and/or microcapsule engineering to improve the activity and stability of Pseudomonas sp. and Candida rugosa lipases in anionic micelles. OTERO, C., ROBLEDO, L., DEL VAL, M. I., Prog. Colloid Polym. Sc., 1996, 100, 296–300.
  • Urinary microalbumin measurement using a homogeneous liposomal immunoassay. FROST, S. J., CHAKRAORTY, J., and FIRTH, G. B., J. Immunol. Methods, 1996, 194 (2), 105–111.
  • Use of biodegradable microspheres in experimental anticancer therapy. Chronopharmaco-logical application. Mims, G., GRANDFILS, C., FLANDROY, P., and BARBASOIq, H., Pathol. Biol. (Paris), 1996, 44 (3), 208–211.
  • Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. KAO, G. Y., CHANG, L. J., and ALLEN, T. M., Cancer Gene. Ther., 1996, 3 (4), 250–256.
  • Video analysis of submerged jet microencapsulation using HEMA-MMA. STEGEMANN, J. P., and SEvroN, M. V., Can. y. Chan. Eng., 1996, 74 (4), 518–525.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.